Legal Notice

1. Website identity

Website name: Greenlaxo
Domain: greenlaxo.info
Country focus: Kenya
Primary language: English
Declared business model: affiliate-supported editorial content.

Greenlaxo is the public site/brand name used by this web resource. It should not be interpreted as a statement that a company with the same name has been incorporated or registered.

2. Purpose of the website

Greenlaxo publishes educational information about prostatitis, chronic pelvic pain, urinary symptoms, appointment preparation and day-to-day lifestyle context. The resource is designed to help readers understand terminology, recognise important warning signs and prepare better questions for qualified healthcare professionals.

The site has editorial value independently of advertising. It is not a doorway page, fake clinic, prescription service, patient portal or disguised redirect. Public users and search crawlers are intended to receive the same editorial site.

3. Public contact information

Address: Eldama Ravine Road, Nairobi, Kenya
Phone: +254 721 850 026
Email: [email protected]

These details were provided specifically for this website build. Business hours were not provided and are therefore not invented. No Google Maps embed is included because no Maps link or embed was provided.

4. Medical and professional status

Greenlaxo does not claim to be a hospital, clinic, pharmacy, laboratory, telemedicine provider or registered medical practice. No named doctors, nurses, urologists, clinical licences, professional registrations, awards or medical certifications were supplied for the site. None are invented in visible content or structured data.

General health information is not individual medical advice. The site cannot examine a reader, review test results, determine the cause of symptoms or prescribe treatment. Users should seek appropriate professional care for diagnosis and treatment.

5. Company, registration and tax information

No legal company name, company registration number, tax number, VAT number or other legal identifier was supplied in the project input. This notice intentionally leaves those details absent. It does not borrow another business's identity, use a placeholder number or present the Nairobi address as proof of a legal entity that has not been identified.

If verified entity information is supplied later, this notice, the site configuration and any relevant schema should be updated consistently.

6. Kenya privacy framework

The site is designed with the Kenya Data Protection Act, 2019 and the Data Protection (General) Regulations, 2021 in mind. Kenya's Office of the Data Protection Commissioner (ODPC) oversees the data-protection framework. Health status is treated as sensitive personal data under the Act, and the Act specifically restricts processing of personal health data.

For that reason, Greenlaxo's contact form is restricted to website, editorial, privacy, technical and partnership matters. It tells users not to submit symptoms, diagnoses, prescriptions, test results or other personal health information. The separate symptom-note tool runs only in the browser and is not submitted to the server.

7. Affiliate and monetisation status

The declared business model is affiliate. In an affiliate relationship, a publisher may receive compensation when a user follows a disclosed tracked link and completes an eligible action with a third party. At the time of this build, no affiliate network, partner or outbound commercial CTA was provided. The supplied site therefore contains no active affiliate offer link or affiliate redirect.

If commercial links are added later, they must be real, clearly disclosed and kept distinguishable from editorial material. Commercial compensation must not be used to manufacture medical claims, imply guaranteed treatment or pressure a user away from necessary professional care.

8. Editorial sources and external references

Greenlaxo may link to public health agencies, regulators, legal databases or Wikimedia Commons for source transparency. Such links are reference links, not endorsements. NIDDK, NHS, the ODPC, Kenya Law and Wikimedia contributors do not thereby sponsor or approve Greenlaxo.

External sites control their own content, availability, security, privacy and later changes. Readers should review important source material directly where appropriate.

9. Copyright, licences and media

Original text, interface design and site code may be protected by applicable intellectual-property law. Open-licensed photographs remain subject to their individual Creative Commons licences or public-domain dedications. The Media Credits page identifies the source file, creator information available from Wikimedia Commons and the applicable licence status used for this build.

When an open image is resized or re-encoded to WEBP, that technical transformation does not remove its attribution or share-alike obligations. Any future replacement image should be checked for licence compatibility before publication.

10. Technical availability and changes

The operator may update, correct, reorganise or temporarily withdraw content for maintenance, legal review or editorial reasons. Greenlaxo does not guarantee uninterrupted availability, compatibility with every browser or permanent availability of an external source.

The deployment environment should use HTTPS, supported PHP versions, appropriate file permissions and normal server security controls. This package cannot truthfully claim a specific hosting provider, firewall, backup schedule or uptime guarantee because those operational details were not supplied.

11. Accessibility and responsible publishing

The site is built with semantic headings, keyboard-accessible navigation, visible focus styles, labelled forms, accessible FAQ controls and reduced-motion support. Accessibility is an ongoing practice; users may report barriers through the contact channel without submitting medical information.

12. Legal, privacy and editorial notices

Notices can be sent to [email protected] or to the postal/street contact address listed above. The public form should not be used to send confidential medical records or personal health histories. Privacy complaints may also be raised with the competent Kenyan data-protection authority where applicable.